Table 4.
Independent variables | Increase medication use | New medication use | Medication use related to WTCD | |||
---|---|---|---|---|---|---|
Adjusted OR | Adjusted 95% CI | Adjusted OR | Adjusted 95% CI | Adjusted OR | Adjusted 95% CI | |
Age (y) | ||||||
18–29 | 1.44 | 0.60–3.43 | 1.63 | 0.59–4.51 | 1.18 | 0.47–2.94 |
30–44 | 1.55 | 0.68–3.51 | 1.50 | 0.56–4.02 | 2.17 | 0.95–4.95 |
45–64 | 1.30 | 0.58–2.92 | 1.52 | 0.57–4.07 | 2.18* | 1.00–4.76 |
65+ (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Gender | ||||||
Male (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Female | 1.47 | 0.93–2.33 | 1.99* | 1.14–3.46 | 1.66* | 1.05–2.60 |
Education | ||||||
Non-college graduate | 1.19 | 0.74–1.93 | 1.61 | 0.91–2.85 | 0.67 | 0.41–1.08 |
College graduate (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Marital status | ||||||
Not married | 1.03 | 0.62–1.71 | 0.67 | 0.36–1.24 | 1.35 | 0.83–2.20 |
Married (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Race | ||||||
White (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
African American | 0.27*** | 0.15–0.51 | 0.20*** | 0.09–0.43 | 0.33*** | 0.19–0.57 |
Latino | 0.75 | 0.41–1.37 | 0.95 | 0.49–1.86 | 0.98 | 0.57–1.69 |
Asian | 0.26* | 0.07–0.95 | 0.19* | 0.04–0.87 | 0.31 | 0.09–1.07 |
Other | 0.33* | 0.12–0.91 | 0.43 | 0.14–1.33 | 0.64 | 0.23–1.80 |
Income | ||||||
<$29,999 | 0.95 | 0.40–2.25 | 0.94 | 0.36–2.48 | 1.20 | 0.56–2.58 |
$30,000–$99,999 | 0.86 | 0.49–1.51 | 0.71 | 0.35–1.45 | 0.80 | 0.44–1.46 |
$100,000+ (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Not reported | 0.47 | 0.17–1.27 | 0.52 | 0.18–1.56 | 0.72 | 0.30–1.75 |
Health insurance | ||||||
No | 0.36* | 0.13–1.00 | 0.17*** | 0.06–0.49 | 0.59 | 0.25–1.36 |
Yes (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Has regular doctor | ||||||
No | 0.50 | 0.18–1.44 | 0.88 | 0.29–2.65 | 0.47 | 0.18–1.32 |
Yes (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Exposure to WTCD | ||||||
Low (0–1 events) (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Moderate (2–3 events) | 1.32 | 0.71–2.46 | 1.16 | 0.56–2.45 | 1.59 | 0.79–3.20 |
High (4–5 events) | 1.66 | 0.90–3.05 | 1.79 | 0.89–3.60 | 2.08* | 1.05–4.13 |
Very high (6+ events) | 1.31 | 0.59–2.92 | 1.58 | 0.63–4.97 | 1.81 | 0.83–3.94 |
Negative life events | ||||||
None (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
One | 1.42 | 0.86–2.35 | 1.19 | 0.63–2.28 | 1.68 | 0.99–2.86 |
2 or more | 1.96* | 1.07–3.57 | 1.21 | 0.63–2.35 | 2.33** | 1.36–3.99 |
Lifetime traumatic events | ||||||
0–1 event (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
2–3 events | 1.26 | 0.73–2.16 | 0.85 | 0.46–1.56 | 0.97 | 0.58–1.61 |
4+ events | 1.22 | 0.73–2.04 | 1.10 | 0.59–2.04 | 0.99 | 0.62–1.59 |
Peri-event panic attack | ||||||
No (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Yes | 1.37 | 0.72–2.62 | 1.17 | 0.56–2.46 | 1.41 | 0.85–2.35 |
BSI-18 anxiety | ||||||
Low (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
High | 1.77 | 0.98–3.16 | 1.83 | 0.89–3.78 | 2.61*** | 1.60–4.26 |
Social support | ||||||
Low | 1.44 | 0.82–2.53 | 1.21 | 0.60–2.48 | 0.65 | 0.35–1.23 |
Moderate | 0.96 | 0.58–1.59 | 0.69 | 0.36–1.33 | 0.84 | 0.52–1.35 |
High (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Self-esteem | ||||||
Low | 1.40 | 0.71–2.78 | 1.63 | 0.75–3.56 | 2.14* | 1.15–3.97 |
Moderate | 1.23 | 0.68–2.22 | 1.48 | 0.76–2.88 | 1.44 | 0.77–2.64 |
High (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
PTSD past year | ||||||
No (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Yes | 1.91* | 1.11–3.29 | 2.14* | 1.19–3.86 | 1.96** | 1.19–3.22 |
Depression past year | ||||||
No (Ref) | 1.00 | – | 1.00 | – | 1.00 | – |
Yes | 3.26*** | 2.02–5.23 | 3.33*** | 1.90–5.84 | 2.63*** | 1.65–4.18 |
Ref = reference category.
All odds ratios and confidence intervals shown represent the weighted data, adjusted for the number of telephone lines and adults in the household, the treatment over-sample, and survey stratification. Regressions are adjusted for all variables shown in table.
P<.05.
P<.01.
P<.001.